Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis
NCT05326048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-03-29
Summary
The objective of APOLLO is therefore to identify biomarkers associated with the CNS involvement phenotype in early MS patients.
Conditions
Interventions
- OTHER
-
cytof analysis
cytof analysis of biological samples of CIS patients. Genomic analysis
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-09
- Primary Completion
- 2022-09-09
- Completion
- 2022-09-09
Countries
- France
Study Locations
More Related Trials
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS
NCT05510817 ·Status: RECRUITING ·Phase: NA
-
EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
NCT02117375 ·Status: UNKNOWN ·Phase: NA
-
Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases
NCT05088473 ·Status: COMPLETED
-
Identifying and Characterizing Preclinical MS
NCT05787795 ·Status: RECRUITING
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis
NCT05451069 ·Status: UNKNOWN
-
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
NCT05633875 ·Status: RECRUITING
-
Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients
NCT01380041 ·Status: TERMINATED
-
MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
NCT03356366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multiple Sclerosis Prediction and Monitoring of Progression Study
NCT05685784 ·Status: RECRUITING ·Phase: NA
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT04873492 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
B Cell Differentiation in MS
NCT03744351 ·Status: COMPLETED ·Phase: NA
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Biomarkers in Multiple Sclerosis
NCT00325988 ·Status: COMPLETED
-
Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis
NCT05077956 ·Status: WITHDRAWN
-
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
NCT07135752 ·Status: RECRUITING ·Phase: NA
-
To Study the Pathophysiological Features of Multiple Sclerosis
NCT04242056 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
NCT00794352 ·Status: RECRUITING
-
Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
NCT01250665 ·Status: UNKNOWN
-
Serum Neurofilament Light in Multiple Sclerosis
NCT06282081 ·Status: ACTIVE_NOT_RECRUITING
-
Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy
NCT00861172 ·Status: COMPLETED ·Phase: NA
-
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
NCT01392872 ·Status: COMPLETED ·Phase: NA